X0306 4 2017-03-23 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001690959 Resnick Joshua ONE BOSTON PLACE, SUITE 3900 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 1 0 0 0 Director Stock Option (Right to Buy) 7.88 2017-03-23 4 A 0 12000 0 A 2027-03-22 Common Stock 12000 12000 D The option vests over a 3 year period: 1/36th on December 21, 2016, after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date. The option is held by the reporting person for the benefit of SV Life Sciences Advisers, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/Benjamin Palleiko, Attorney-in-fact 2017-03-27